Clinical trial · Interventional
Clinical Evaluation of Opto-Acoustic Image Quality With the Gen 2 Imagio System
NCT05022602CI-TRIAL-00065106completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study performs the first clinical evaluation of the Gen 2 Imagio System in a clinical setting to assess image quality with both the IUS ultrasound only probe and the OA/US (duplex probe).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Stage | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Imagio | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Imagio
- description
- Imagio Grayscale only probe and Imagio Duplex probe in ultrasound only and OA modes
- interventionNames
- Device: Imagio
Primary outcomes (2)
- measure
- Number of Participants With Imagio Image Sets Collected
- timeFrame
- Baseline
- description
- Obtain ultrasound only probe images and OA/US (both gray scale and OA) probe images as measured by the receipt of image sets for each subject enrolled.
- measure
- Number of Subjects With Completed Pathology Results
- timeFrame
- Baseline
- description
- Provide breast pathology results per subject (except BI-RADS 1, 2 and 3 (as applicable)) if subject's study mass is biopsied
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Has a signed and dated informed consent, prior to initiation of any study-related activities. 2. Is at least 18 years of age. 3. Have been referred for a breast US because of a breast lesion/mass finding via a palpable lump or per standard of care imaging. 4. Is willing and able to comply with protocol-required scans Exclusion Criteria: 1. Is pregnant or lactating. 2. Has a condition or breast impediment (i.e. insect bites, poison ivy, rash, open wounds, chafing of the skin, scar, tattoos, moles, hematoma, nipple rings, etc.) which could interfere with the intended field of view. 3. Is experiencing photo-toxicity associated with currently taking, or having taken, photosensitizing agents within the previous 72 hours such as some sulfur containing drugs, ampicillin, tetracycline. 4. Is currently undergoing phototherapy. 5. Has a history of any photosensitive disease (e.g., porphyria, lupus erythematosus) or undergoing treatment for a photosensitive disease and is experiencing photosensitivity. 6. Has had an adverse reaction in the past to medical laser procedures, such as laser hair removal or laser tattoo removal. 7. Has had prior benign excisional breast biopsy on breast of interest within the past 18 months. 8. Currently has mastitis. 9. Prisoners
References
Publications (0)
Data not yet available
No reference posted for this study.